COVID-19 Webinars

In December 2019, an outbreak of pneumonia cases of unknown cause emerged in the city of Wuhan, China. On January 9th, 2020, the World Health Organization and the Chinese Health Authorities announced the discovery of a novel coronavirus, SARS-CoV-2. This new virus is responsible for the infectious respiratory disease called COVID-19 (COronaVIrus Disease).

国产微拍福利Since then, the situation has rapidly evolved worldwide and the outbreak was declared a public health emergency of international concern on January 30, 2020, and a pandemic on March 11, 2020. Scientists have been working at a tremendous and unprecedented pace to better understand the disease, test existing drugs, and develop diagnostic tests and vaccines.

In this section, you will find recorded webinars around COVID-19 and the value of diagnostic tests led by leading Experts and sponsored by bioMérieux as well as links to external educational content independently supported by bioMérieux.

The Role of RT-PCR & Serology Tests in the Diagnosis and Management of COVID-19 Patients

Testing is a crucial step in controlling the novel COVID-19 pandemic. During this webinar, Professor Lina will share his experience about the use and positioning of both RT-PCR and serology tests in the diagnosis of COVID-19, address their value and limitations and, will also cover the impact of virus genetic evolution on diagnostics and expectation for immunity. Finally, Professor Lina will present the lessons learned from this first pandemic wave and his views and considerations about a possible second wave.

 

   

   

  

  


 

Emergency Room: Key Biomarkers in managing COVID-19 suspected patients

Professor Hausfater will share his current experience and considerations for a possible second wave about the role of biomarkers in the management of suspected COVID-19 patients and in the monitoring of potential complications including organ failures.

   

国产微拍福利   

  

  


Introduction to Severe Lower-Tract Infections

In this first Webinar of the program, Dr. Fabio Varón (internist, intensivist and pulmonologist of the Colombian Pulmonology Foundation) presents an introduction to severe respiratory tract infections. Dr. Varón quickly presents the topics that will be developed in other talks of the program: etiology; etiological diagnosis, radiological diagnosis and biomarkers; symptomatic and antimicrobial treatment; early detection of hypoxemia, its mechanisms and management. Each of the topics presented is illustrated in the context of the COVID-19 pandemic situation.

      

   


SARS-CoV-2 Diagnostics

This webinar address the main topics in microbiology diagnostics in severe pneumonia including Covid-19 in order to understand the value of different diagnostics approach based in the clinical and epidemiologic scenarios. There has been a lot of discussion about the importance of testing in COVID-19, the sensitivity and the specificity of the tests, and whom and when should be tested. Dr. Ginocchio is Global Medical Affairs VP in bioMérieux and BioFire Diagnostics.

    

   

   


Advanced Mechanical Ventilation in the Patient with COVID-19-associated Severe Pneumonia and Acute Respiratory Distress Syndrome

Dr. Fabio Varón (internist, intensivist and pulmonologist of the Colombian Pulmonology Foundation) presents the mechanisms of the pathogenesis of COVID-19 leading to hospitalization in intensive care, particularly hypoxemia, viral pneumonia, coagulopathy, cytokine storms, and Acute Respiratory Distress Syndrome. Dr. Varón explains the different ventilation strategies available according to the clinical presentation of the critical patient, and strategies to reduce the risk of contagion for health personnel in each of these situations.

      

   


Sepsis in COVID-19: Treatment and Management based on pathophysiology

This is a new global war! A world was not prepared for this threat! A disease (viruses) that has changed health and the world. Hospitals and ICUs are fully saturated and without human or material resources in whole world. Pandemic viral disease = system failure. Dr. Marcio Borges explain in this webinar the management ant the treatment base on the pathophysiology of Sepsis caused by COVID-19. Dr. Borges is Critical Care specialist in Spain and is Sepsis Director of FEPIMCTI.

      

   


Pneumonia Management in Pediatric Patients

Respiratory tract infections are the most common cause of ED and external consultation in pediatric patients. COVID-19 has been less common in children, and many questions have become in this topic.  Dra. Analia De Cristófano ID and pediatrician physician bring us the light  on the management of severe pneumonia in the context of a pandemic in this vulnerable population.

      

   


The importance of Biomarkers in Respiratory Tract Infections and in COVID-19 Pneumonia

In COVID-19, sometimes is not enough to know that the patient has an infection from SARS-CoV-2, this webinar reinforce the utility of biomarkers in the context of severe pneumonia including Covid-19, to asses severity, prognosis and to better understand the evolution in order to guide the appropriate therapy. Dr. Rodríguez is Critical Care specialist in Terragona, Spain and Director of the Group of Research in Sepsis and Severe Respiratory Tract Infections.

      

   


Rational use of Antimicrobial Agents in the era of COVID-19

How to imagine the world without effective antimicrobials?  The rational use of antimicrobials will depend on our conscious actions as a critical element to avoid the increase of antimicrobial resistance. It is necessary, in the global health context that we have to go through, to know the recommendations on the appropriate treatments in patients with COVID - 19. Rodolfo Quirós an ID physician in Bolivia performs a review on one of the most critical issues worldwide.

      

   

 


The content on this website and associated materials do not constitute medical advice and should not be considered a substitute for the individual professional judgement of any physician or other health care practitioner regarding the appropriate course of action for a particular patient. All recommendations should be independently reviewed with appropriate medical staff in light of the needs of any particular institution and its patients. bioMérieux makes no guarantee or representation regarding the accuracy, completeness, or usefulness of this information for any particular purpose, including but not limited to any cost savings.